Pneumoconiosis

Pneumoconiosis Treatment

Pneumoconiosis treatment

Alternative Pneumoconiosis Treatment Offered at the Lung Institute

Common pneumoconiosis treatment options include medications, lifestyle changes and activity modifications. Even though this condition, which is also known as black lung disease, cannot be cured, many people are able to manage their symptoms by using supplemental oxygen, taking prescription medications to keep their lung passages open and avoiding tobacco products and dust exposure.

A newer, innovative pneumoconiosis treatment option is cellular therapy, in which a patient’s own cells are used to help reduce inflammation and promote healing. Unlike some other treatments, cellular therapy has the potential to slow the progression of the disease. Many people who undergo cellular therapy for pneumoconiosis report not only an improvement in their quality of life, but also a reduced dependence on medications and supplemental oxygen.  At the Lung Institute, we offer cellular therapy as pneumoconiosis treatment. In our Blood-Derived Therapy, the cells are taken from the patient’s blood. Autologous cell procedures are performed on an outpatient basis over the course of two days and consist of three simple steps:

  • Our experienced medical professionals take a blood sample from the patient
  • In our onsite lab, we separate out the cells
  • We return the concentrated cells to the patient’s body, and after a short monitoring period, the patient can return to the hotel accommodations

We are committed to helping each patient achieve the best possible outcome for his or her pneumoconiosis treatment. After the procedure, our medical team conducts comprehensive follow-up care and coordinates with the other members of the patient’s treatment team, including his or her primary care physician and pulmonologist.

For more information about cellular therapy as an alternative pneumoconiosis treatment, or for more facts about black lung disease, call the Lung Institute at (800) 729-3065. Our dedicated staff can help you determine if cellular therapy may be right for you.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.